Correlation Between Kandi Technologies and Inhibrx
Can any of the company-specific risk be diversified away by investing in both Kandi Technologies and Inhibrx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kandi Technologies and Inhibrx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Kandi Technologies Group and Inhibrx, you can compare the effects of market volatilities on Kandi Technologies and Inhibrx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kandi Technologies with a short position of Inhibrx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kandi Technologies and Inhibrx.
Diversification Opportunities for Kandi Technologies and Inhibrx
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Kandi and Inhibrx is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Kandi Technologies Group and Inhibrx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Inhibrx and Kandi Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kandi Technologies Group are associated (or correlated) with Inhibrx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Inhibrx has no effect on the direction of Kandi Technologies i.e., Kandi Technologies and Inhibrx go up and down completely randomly.
Pair Corralation between Kandi Technologies and Inhibrx
Given the investment horizon of 90 days Kandi Technologies Group is expected to under-perform the Inhibrx. In addition to that, Kandi Technologies is 1.82 times more volatile than Inhibrx. It trades about -0.15 of its total potential returns per unit of risk. Inhibrx is currently generating about -0.09 per unit of volatility. If you would invest 1,743 in Inhibrx on September 15, 2024 and sell it today you would lose (281.00) from holding Inhibrx or give up 16.12% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Kandi Technologies Group vs. Inhibrx
Performance |
Timeline |
Kandi Technologies |
Inhibrx |
Kandi Technologies and Inhibrx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Kandi Technologies and Inhibrx
The main advantage of trading using opposite Kandi Technologies and Inhibrx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kandi Technologies position performs unexpectedly, Inhibrx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Inhibrx will offset losses from the drop in Inhibrx's long position.Kandi Technologies vs. Ford Motor | Kandi Technologies vs. General Motors | Kandi Technologies vs. Goodyear Tire Rubber | Kandi Technologies vs. Li Auto |
Inhibrx vs. Puma Biotechnology | Inhibrx vs. Iovance Biotherapeutics | Inhibrx vs. Day One Biopharmaceuticals | Inhibrx vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |